WIRED article: Big Pharma Buys Into Crowdsourcing For Drug Discovery

In this piece posted on WIRED on July 17th 2017, Menaka Wilhelm describes the reasons why SGC has chosen to practice "extreme openness" in drug design by sharing data and research material with the world. This open approach is supported by SGC's pharma partners, the pharmaceutical companies that fund and collaborate with the SGC, and by SGC's public funders who collectively recognize the value of open-source science in speeding up drug discovery and ultimately developing new medicines to save patients' lives.

For the full article: https://www.wired.com/story/big-pharma-buys-into-crowdsourcing-for-drug-...